{"pmid":32329138,"title":"Who should perform the rhinopharyngeal swab in COVID-19 positive patients?","text":["Who should perform the rhinopharyngeal swab in COVID-19 positive patients?","Head Neck","De Virgilio, Armando","Pellini, Raul","Mercante, Giuseppe","Ferreli, Fabio","Petruzzi, Gerardo","Spriano, Giuseppe","32329138"],"journal":"Head Neck","authors":["De Virgilio, Armando","Pellini, Raul","Mercante, Giuseppe","Ferreli, Fabio","Petruzzi, Gerardo","Spriano, Giuseppe"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32329138","week":"202017|Apr 20 - Apr 26","doi":"10.1002/hed.26194","keywords":["covid-19","oropharynx","otorhinolaryngologists","swab: rhinopharynx"],"source":"PubMed","topics":["Diagnosis","Prevention"],"weight":1,"_version_":1664996914860392449,"score":8.518259,"similar":[{"pmid":32270938,"title":"[Covid-19 diagnosis : clinical recommendations and performance of nasopharyngeal swab-PCR].","text":["[Covid-19 diagnosis : clinical recommendations and performance of nasopharyngeal swab-PCR].","The Covid-19 pandemic imposes new diagnostic strategies in order to optimize the medical care of our patients. The current biblio-graphy, although of low quality, shows a sensitivity of 56 to 83 % for the Covid-19 PCR. Even though one negative test can exclude a Covid-19 in the majority of cases, the NPV (Negative Predictive Value) decreases with increasing prevalence (pre-test probability). This finding suggests the need for strict auto-isolation of patients until the resolution of their symptoms. For patients that present with typical symptoms, who have a presumed Covid-19 prevalence of -40-50 %, a negative test should be interpreted with caution and a repeat test may be needed.","Rev Med Suisse","Kokkinakis, Ioannis","Selby, Kevin","Favrat, Bernard","Genton, Blaise","Cornuz, Jacques","32270938"],"abstract":["The Covid-19 pandemic imposes new diagnostic strategies in order to optimize the medical care of our patients. The current biblio-graphy, although of low quality, shows a sensitivity of 56 to 83 % for the Covid-19 PCR. Even though one negative test can exclude a Covid-19 in the majority of cases, the NPV (Negative Predictive Value) decreases with increasing prevalence (pre-test probability). This finding suggests the need for strict auto-isolation of patients until the resolution of their symptoms. For patients that present with typical symptoms, who have a presumed Covid-19 prevalence of -40-50 %, a negative test should be interpreted with caution and a repeat test may be needed."],"journal":"Rev Med Suisse","authors":["Kokkinakis, Ioannis","Selby, Kevin","Favrat, Bernard","Genton, Blaise","Cornuz, Jacques"],"date":"2020-04-10T11:00:00Z","year":2020,"_id":"32270938","week":"202015|Apr 06 - Apr 12","source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664637315662741504,"score":73.05052},{"pmid":32335176,"title":"Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19).","text":["Positive rectal swabs in young patients recovered from coronavirus disease 2019 (COVID-19).","OBJECTIVES: To investigate the widely concerned issue about positive real-time reverse transcription polymerase chain reaction (RT-PCR) test results after discharge in patients recovered from coronavirus disease 2019 (COVID-19). METHODS: We identified seven cases of COVID-19 who was readmitted to hospital because of positive RT-PCR after discharge, including three pediatrics and four young adult patients. RESULTS: Six patients had positive rectal swabs but negative throat swabs, and one patient had positive throat swabs. All the patients continued to be asymptomatic and had unchanged chest computed tomography from previous images. The time from hospital discharge to positive RT-PCR after recovery was 7-11 days. The time from positive to negative rectal swabs was 5-23 days. CONCLUSION: The study might suggest the positive RT-PCR after recovery did not mean disease relapse or virus reinfection. Adding RT-PCR test of rectal swabs to the criteria for discharge or discontinuation of quarantine might be necessary.","J Infect","Zhang, Bin","Liu, Shuyi","Dong, Yuhao","Zhang, Lu","Zhong, Qingyang","Zou, Yujian","Zhang, Shuixing","32335176"],"abstract":["OBJECTIVES: To investigate the widely concerned issue about positive real-time reverse transcription polymerase chain reaction (RT-PCR) test results after discharge in patients recovered from coronavirus disease 2019 (COVID-19). METHODS: We identified seven cases of COVID-19 who was readmitted to hospital because of positive RT-PCR after discharge, including three pediatrics and four young adult patients. RESULTS: Six patients had positive rectal swabs but negative throat swabs, and one patient had positive throat swabs. All the patients continued to be asymptomatic and had unchanged chest computed tomography from previous images. The time from hospital discharge to positive RT-PCR after recovery was 7-11 days. The time from positive to negative rectal swabs was 5-23 days. CONCLUSION: The study might suggest the positive RT-PCR after recovery did not mean disease relapse or virus reinfection. Adding RT-PCR test of rectal swabs to the criteria for discharge or discontinuation of quarantine might be necessary."],"journal":"J Infect","authors":["Zhang, Bin","Liu, Shuyi","Dong, Yuhao","Zhang, Lu","Zhong, Qingyang","Zou, Yujian","Zhang, Shuixing"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335176","week":"202018|Apr 27 - May 03","doi":"10.1016/j.jinf.2020.04.023","keywords":["covid-19","hospital discharge","positive rt-pcr","rectal swabs"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1665172301987971073,"score":65.61745},{"pmid":32329026,"title":"Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab.","text":["Study of SARS-CoV-2 in semen and urine samples of a volunteer with positive naso-pharyngeal swab.","INTRODUCTION: The recent appearance of SARS-CoV-2 in Wuhan in 2019 has started a pandemic which has involved over a million people worldwide. A matter of debate is the possible viral detection in different body fluids than respiratory droplets. Thus, we evaluated the possible presence of SARS-CoV-2 in semen and urine samples of a volunteer with confirmed COVID-19. MATERIALS AND METHODS: A 31-year-old man with fever, myalgia, anosmia, and ageusia was tested and found positive for SARS-CoV-2 through a pharyngeal swab. Eight days after he provided semen and urine samples in which viral RNA presence was measured using a Real time RT PCR system (RealStar SARS-CoV-2 RT-PCR, Altona Diagnostics) targeting E and S viral genes. RESULTS AND DISCUSSION: Semen and urine samples search for SARS-CoV-2 RNA was negative. Although this should be interpreted cautiously, it may be possible that either the viral clearance kinetics in these matrices matches the progressive clinical recovery of the patient or that the virus was never present in these fluids at the time of the laboratory diagnosis.","J Endocrinol Invest","Paoli, D","Pallotti, F","Colangelo, S","Basilico, F","Mazzuti, L","Turriziani, O","Antonelli, G","Lenzi, A","Lombardo, F","32329026"],"abstract":["INTRODUCTION: The recent appearance of SARS-CoV-2 in Wuhan in 2019 has started a pandemic which has involved over a million people worldwide. A matter of debate is the possible viral detection in different body fluids than respiratory droplets. Thus, we evaluated the possible presence of SARS-CoV-2 in semen and urine samples of a volunteer with confirmed COVID-19. MATERIALS AND METHODS: A 31-year-old man with fever, myalgia, anosmia, and ageusia was tested and found positive for SARS-CoV-2 through a pharyngeal swab. Eight days after he provided semen and urine samples in which viral RNA presence was measured using a Real time RT PCR system (RealStar SARS-CoV-2 RT-PCR, Altona Diagnostics) targeting E and S viral genes. RESULTS AND DISCUSSION: Semen and urine samples search for SARS-CoV-2 RNA was negative. Although this should be interpreted cautiously, it may be possible that either the viral clearance kinetics in these matrices matches the progressive clinical recovery of the patient or that the virus was never present in these fluids at the time of the laboratory diagnosis."],"journal":"J Endocrinol Invest","authors":["Paoli, D","Pallotti, F","Colangelo, S","Basilico, F","Mazzuti, L","Turriziani, O","Antonelli, G","Lenzi, A","Lombardo, F"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32329026","week":"202017|Apr 20 - Apr 26","doi":"10.1007/s40618-020-01261-1","keywords":["covid-19","pharyngeal swab","sars-cov-2","semen fluid"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan","myalgia"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664996914883461122,"score":59.31177},{"pmid":32295896,"title":"Nasal swab sampling for SARS-CoV-2: A convenient alternative in time of nasopharyngeal swab shortage.","text":["Nasal swab sampling for SARS-CoV-2: A convenient alternative in time of nasopharyngeal swab shortage.","Nasopharyngeal swab is the reference sampling method to detect SARS CoV2, as recommended by world Health Organization (WHO) (1).....","J Clin Microbiol","Pere, Helene","Podglajen, Isabelle","Wack, Maxime","Flamarion, Edouard","Mirault, Tristan","Goudot, Guillaume","Hauw-Berlemont, Caroline","Le, Laetitia","Caudron, Eric","Carrabin, Sophie","Rodary, Julien","Ribeyre, Tatiana","Belec, Laurent","Veyer, David","32295896"],"abstract":["Nasopharyngeal swab is the reference sampling method to detect SARS CoV2, as recommended by world Health Organization (WHO) (1)....."],"journal":"J Clin Microbiol","authors":["Pere, Helene","Podglajen, Isabelle","Wack, Maxime","Flamarion, Edouard","Mirault, Tristan","Goudot, Guillaume","Hauw-Berlemont, Caroline","Le, Laetitia","Caudron, Eric","Carrabin, Sophie","Rodary, Julien","Ribeyre, Tatiana","Belec, Laurent","Veyer, David"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32295896","week":"202016|Apr 13 - Apr 19","doi":"10.1128/JCM.00721-20","source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664641388423151617,"score":51.834946},{"pmid":32330305,"title":"SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens.","text":["SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens.","PURPOSE: The purpose of this study was to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) ribonucleic acid (RNA) in urine and blood specimens, and anal and oropharyngeal swabs from patients with confirmed SARS-CoV-2 infection, and correlated positive results with clinical findings. METHODS: Patients with confirmed SARS-CoV-2 infections were included in this study. Patients' demographic and clinical data were recorded. Quantitative real-time PCR was used to detect SARS-CoV-2 RNA in urine and blood specimens, and anal and oropharyngeal swabs. The study is registered at ClinicalTrials.gov (No. NCT04279782, February 19, 2020). RESULTS: SARS-CoV-2 RNA was present in all 4 specimen types, though not all specimen types were positive simultaneously. The presence of viral RNA was not necessarily predictive of clinical symptoms, e.g., the presence of viral RNA in the urine did not necessarily predict urinary tract symptoms. CONCLUSIONS: SARS-CoV-2 can infect multiple systems, including the urinary tract. Testing different specimen types may be useful for monitoring disease changes and progression, and for establishing a prognosis. This article is protected by copyright. All rights reserved.","J Med Virol","Peng, Liang","Liu, Jing","Xu, Wenxiong","Luo, Qiumin","Chen, Dabiao","Lei, Ziying","Huang, Zhanlian","Li, Xuejun","Deng, Keji","Lin, Bingliang","Gao, Zhiliang","32330305"],"abstract":["PURPOSE: The purpose of this study was to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) ribonucleic acid (RNA) in urine and blood specimens, and anal and oropharyngeal swabs from patients with confirmed SARS-CoV-2 infection, and correlated positive results with clinical findings. METHODS: Patients with confirmed SARS-CoV-2 infections were included in this study. Patients' demographic and clinical data were recorded. Quantitative real-time PCR was used to detect SARS-CoV-2 RNA in urine and blood specimens, and anal and oropharyngeal swabs. The study is registered at ClinicalTrials.gov (No. NCT04279782, February 19, 2020). RESULTS: SARS-CoV-2 RNA was present in all 4 specimen types, though not all specimen types were positive simultaneously. The presence of viral RNA was not necessarily predictive of clinical symptoms, e.g., the presence of viral RNA in the urine did not necessarily predict urinary tract symptoms. CONCLUSIONS: SARS-CoV-2 can infect multiple systems, including the urinary tract. Testing different specimen types may be useful for monitoring disease changes and progression, and for establishing a prognosis. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Peng, Liang","Liu, Jing","Xu, Wenxiong","Luo, Qiumin","Chen, Dabiao","Lei, Ziying","Huang, Zhanlian","Li, Xuejun","Deng, Keji","Lin, Bingliang","Gao, Zhiliang"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330305","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25936","keywords":["sars-cov-2","prognosis","real-time polymerase chain reaction","specimens","urine"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1664996914914918401,"score":51.834946}]}